Zack Rosenbloom

Investment Research Director at Gaingels

Zack Rosenbloom is currently the Investment Research Director at Gaingels, a role he has held since February 2023. He is based in New York City and has a background in investment research and management within the startup ecosystem.

Professional Experience

Gaingels
- Investment Research Director (February 2023 - Present)
- Investment Research Manager (June 2022 - February 2023)
- Research Operations Associate (September 2021 - June 2022)

In his positions at Gaingels, Rosenbloom has been responsible for managing deal flow and investment content strategy across various syndication channels. He has also prepared investment memos for deal syndication, showcasing his expertise in investment research and analysis.

Prior to his tenure at Gaingels, he co-founded and served as the Chief Operating Officer of Bidversity from June 2020 to September 2021. He also worked at Pfizer in various roles related to rare diseases, where he contributed to research and operational support for business development projects.

Education

Rosenbloom holds a Bachelor of Science in Cellular and Molecular Biology and Management and Legal Studies in Business from Tulane University, where he graduated in 2019. He also completed an Applied Data Science course at the Massachusetts Institute of Technology in 2021.

Skills and Interests

He describes himself as a generalist and a quick learner with a strong interest in startups, indicating a versatile skill set that spans investment research, operational strategy, and business development.1

Experience

Investment Research Director at Gaingels (February 2023 - Present)

Investment Research Manager at Gaingels (June 2022 - February 2023), Research Operations Associate at Gaingels (September 2021 - June 2022), Co-Founder & Chief Operating Officer at Bidversity (June 2020 - September 2021), Rare Disease Research Associate at Pfizer (November 2019 - July 2020), Medical Project Manager at Trois Prime Inc. (February 2019 - November 2019), Business Development and Implementation Strategist at ReSuture (February 2019 - July 2019), Rare Disease Medical Affairs Intern at Pfizer (May 2018 - October 2018), Business Analyst at Tefen Management Consulting (May 2017 - September 2017)

Education

Bachelor of Science - BS, Cellular and Molecular Biology at Tulane University (2015 - 2019), Applied Data Science Course in Data Processing at Massachusetts Institute of Technology (2021), Bachelor of Science - BS, Management and Legal Studies in Business at Tulane University (2015 - 2019), Study Abroad Semester, Biology/Biological Sciences at King's College London (2017 - 2018), Oncology and Cancer Biology Non-Credit Summer Class at Emory University (2014)